{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:00Z","timestamp":1772119980524,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS-5027-02-2020"],"award-info":[{"award-number":["KFS-5027-02-2020"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS-5302-02-2021"],"award-info":[{"award-number":["KFS-5302-02-2021"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["KFS-5027-02-2020"],"award-info":[{"award-number":["KFS-5027-02-2020"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stiftung f\u00fcr krebskranke Kinder - Regio Basiliensis"},{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","award":["KLS\/KFS-4825-01-2019"],"award-info":[{"award-number":["KLS\/KFS-4825-01-2019"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Childhood Cancer Switzerland"},{"name":"Kinderkrebshilfe Schweiz"},{"name":"University of Basel Research Fund for Excellent Junior Researchers"},{"name":"University of Bern"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Langerhans cell histiocytosis (LCH) is a rare disease characterized by dysregulated proliferation of myeloid marrow progenitors and subsequent organ infiltration. While LCH is associated with a favorable prognosis, some survivors may develop chronic health conditions (CHC) because of the disease. In this study, we aimed to assess the spectrum and prevalence of CHC among LCH survivors compared with siblings and identify factors associated with the development of CHC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Swiss Childhood Cancer Survivor Study sent questionnaires to all\u2009\u2265\u20095-year LCH survivors registered in the Swiss Childhood Cancer Registry and diagnosed between 1976 and 2015. Siblings also received similar questionnaires. We compared CHC prevalence between LCH survivors and siblings and used logistic regression to identify determinants of CHC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 123 LCH survivors participated in the study, with a response rate of 69%. Median time since diagnosis was 13\u00a0years (interquartile range 9\u201320). Among LCH survivors, 59% had at least one CHC. Cardiovascular (13% vs. 6%), endocrine (15% vs. 2%), musculoskeletal (22% vs. 13%), and digestive (15% vs. 8%) CHC were more common among LCH survivors compared to siblings (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Factors most strongly associated with the occurrence of CHC were multisystem LCH, multifocal bone involvement, and involvement of the pituitary gland.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>More than half of long-term LCH survivors suffered from one or more CHC and were affected considerably more than siblings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications for Cancer Survivors<\/jats:title>\n                    <jats:p>LCH survivors in follow-up care should be screened especially for cardiovascular, endocrine, musculoskeletal, and digestive conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11764-024-01544-z","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T10:03:02Z","timestamp":1707904982000},"page":"1212-1221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic health conditions after childhood Langerhans cell histiocytosis: Results from the Swiss Childhood Cancer Survivor Study"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4422-479X","authenticated-orcid":false,"given":"Tom\u00e1\u0161","family":"Sl\u00e1ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5613-4356","authenticated-orcid":false,"given":"Luzius","family":"Mader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0220-5566","authenticated-orcid":false,"given":"Ma\u0161a","family":"\u017darkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reta","family":"Mal\u00e4r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-8709","authenticated-orcid":false,"given":"Alexandra","family":"Schifferli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9555-3817","authenticated-orcid":false,"given":"Nicolas X.","family":"von der Weid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8957-2002","authenticated-orcid":false,"given":"Claudia E.","family":"Kuehni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4511-287X","authenticated-orcid":false,"given":"Christina","family":"Schindera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"1544_CR1","doi-asserted-by":"crossref","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36(7):1703\u201319.","DOI":"10.1038\/s41375-022-01613-1"},{"issue":"1","key":"1544_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/pbc.21504","volume":"51","author":"H Stalemark","year":"2008","unstructured":"Stalemark H, Laurencikas E, Karis J, Gavhed D, Fadeel B, Henter JI. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 2008;51(1):76\u201381.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1544_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/pbc.21498","volume":"51","author":"A Guyot-Goubin","year":"2008","unstructured":"Guyot-Goubin A, Donadieu J, Barkaoui M, Bellec S, Thomas C, Clavel J. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000\u20132004. Pediatr Blood Cancer. 2008;51(1):71\u20135.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"1544_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/0959-8049(95)00091-7","volume":"31A","author":"P Kaatsch","year":"1995","unstructured":"Kaatsch P, Haaf G, Michaelis J. Childhood malignancies in Germany\u2013methods and results of a nationwide registry. Eur J Cancer. 1995;31A(6):993\u20139.","journal-title":"Eur J Cancer"},{"issue":"5","key":"1544_CR5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/adc.2008.144527","volume":"94","author":"JA Salotti","year":"2009","unstructured":"Salotti JA, Nanduri V, Pearce MS, Parker L, Lynn R, Windebank KP. Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Arch Dis Child. 2009;94(5):376\u201380.","journal-title":"Arch Dis Child"},{"issue":"2","key":"1544_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0889-8588(05)70508-6","volume":"12","author":"M Arico","year":"1998","unstructured":"Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12(2):247\u201358.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"1544_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/pbc.24367","volume":"60","author":"R Haupt","year":"2013","unstructured":"Haupt R, Minkov M, Astigarraga I, Schafer E, Nanduri V, Jubran R, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60(2):175\u201384.","journal-title":"Pediatr Blood Cancer"},{"key":"1544_CR8","doi-asserted-by":"publisher","unstructured":"Sterlich K, Minkov M. Childhood langerhans cell histiocytosis: epidemiology, clinical presentations, prognostic factors, and therapeutic approaches. In: T. Valarmathi M, editor. Rare Diseases - Diagnostic and Therapeutic Odyssey [Internet]. IntechOpen; 2021. Available from: https:\/\/doi.org\/10.5772\/intechopen.92919","DOI":"10.5772\/intechopen.92919"},{"issue":"2","key":"1544_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2165\/11538540-000000000-00000","volume":"13","author":"M Minkov","year":"2011","unstructured":"Minkov M. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions. Paediatr Drugs. 2011;13(2):75\u201386.","journal-title":"Paediatr Drugs"},{"issue":"25","key":"1544_CR10","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1182\/blood-2012-09-455774","volume":"121","author":"H Gadner","year":"2013","unstructured":"Gadner H, Minkov M, Grois N, Potschger U, Thiem E, Arico M, et al. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013;121(25):5006\u201314.","journal-title":"Blood"},{"issue":"12","key":"1544_CR11","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1001\/jama.290.12.1583","volume":"290","author":"MM Hudson","year":"2003","unstructured":"Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003;290(12):1583\u201392.","journal-title":"JAMA"},{"issue":"15","key":"1544_CR12","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572\u201382.","journal-title":"N Engl J Med"},{"issue":"5","key":"1544_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/pbc.20021","volume":"42","author":"R Haupt","year":"2004","unstructured":"Haupt R, Nanduri V, Calevo MG, Bernstrand C, Braier JL, Broadbent V, et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer. 2004;42(5):438\u201344.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1544_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/bjh.17243","volume":"192","author":"K Sakamoto","year":"2021","unstructured":"Sakamoto K, Morimoto A, Shioda Y, Imamura T, Imashuku S, Japan LCHSG. Long-term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow-up of the JLSG-96\/02 studies. Br J Haematol. 2021;192(3):615\u201320.","journal-title":"Br J Haematol."},{"issue":"5","key":"1544_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/08880010050034300","volume":"17","author":"P Kusumakumary","year":"2000","unstructured":"Kusumakumary P, James FV. Permanent disabilities in childhood survivors of Langerhans cell histiocytosis. Pediatr Hematol Oncol. 2000;17(5):375\u201381.","journal-title":"Pediatr Hematol Oncol"},{"issue":"15","key":"1544_CR16","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.ejca.2006.05.031","volume":"42","author":"VR Nanduri","year":"2006","unstructured":"Nanduri VR, Pritchard J, Levitt G, Glaser AW. Long term morbidity and health related quality of life after multi-system Langerhans cell histiocytosis. Eur J Cancer. 2006;42(15):2563\u20139.","journal-title":"Eur J Cancer"},{"issue":"4","key":"1544_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/mpo.2950210405","volume":"21","author":"A Ceci","year":"1993","unstructured":"Ceci A, de Terlizzi M, Colella R, Loiacono G, Balducci D, Surico G, et al. Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-H.X \u201983 study. Med Pediatr Oncol. 1993;21(4):259\u201364.","journal-title":"Med Pediatr Oncol."},{"issue":"7","key":"1544_CR18","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1200\/JCO.1996.14.7.2073","volume":"14","author":"B Willis","year":"1996","unstructured":"Willis B, Ablin A, Weinberg V, Zoger S, Wara WM, Matthay KK. Disease course and late sequelae of Langerhans\u2019 cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol. 1996;14(7):2073\u201382.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1544_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1651-2227.2005.tb02048.x","volume":"94","author":"C Bernstrand","year":"2005","unstructured":"Bernstrand C, Sandstedt B, Ahstrom L, Henter JI. Long-term follow-up of Langerhans cell histiocytosis: 39 years\u2019 experience at a single centre. Acta Paediatr. 2005;94(8):1073\u201384.","journal-title":"Acta Paediatr"},{"issue":"1","key":"1544_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/pbc.20760","volume":"48","author":"E Mittheisz","year":"2007","unstructured":"Mittheisz E, Seidl R, Prayer D, Waldenmair M, Neophytou B, Potschger U, et al. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007;48(1):50\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"1544_CR21","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/archdischild-2016-312185","volume":"102","author":"TW Chow","year":"2017","unstructured":"Chow TW, Leung WK, Cheng FWT, Kumta SM, Chu WCW, Lee V, et al. Late outcomes in children with Langerhans cell histiocytosis. Arch Dis Child. 2017;102(9):830\u20135.","journal-title":"Arch Dis Child"},{"issue":"3","key":"1544_CR22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/pbc.21322","volume":"50","author":"LM Lau","year":"2008","unstructured":"Lau LM, Stuurman K, Weitzman S. Skeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivors. Pediatr Blood Cancer. 2008;50(3):607\u201312.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"1544_CR23","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/ije\/dyr142","volume":"41","author":"CE Kuehni","year":"2012","unstructured":"Kuehni CE, Rueegg CS, Michel G, Rebholz CE, Strippoli MP, Niggli FK, et al. Cohort profile: the Swiss childhood cancer survivor study. Int J Epidemiol. 2012;41(6):1553\u201364.","journal-title":"Int J Epidemiol"},{"issue":"35\u201336","key":"1544_CR24","first-page":"502","volume":"137","author":"G Michel","year":"2007","unstructured":"Michel G, von der Weid NX, Zwahlen M, Adam M, Rebholz CE, Kuehni CE, et al. The Swiss Childhood Cancer Registry: rationale, organisation and results for the years 2001\u20132005. Swiss Med Wkly. 2007;137(35\u201336):502\u20139.","journal-title":"Swiss Med Wkly"},{"key":"1544_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canep.2019.06.002","volume":"61","author":"G Sommer","year":"2019","unstructured":"Sommer G, Schindler M, Redmond S, Pfeiffer V, Konstantinoudis G, Ammann RA, et al. Temporal trends in incidence of childhood cancer in Switzerland, 1985\u20132014. Cancer Epidemiol. 2019;61:157\u201364.","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"1544_CR26","first-page":"45","volume":"88","author":"LL Robison","year":"2005","unstructured":"Robison LL. The Childhood Cancer Survivor Study: a resource for research of long-term outcomes among adult survivors of childhood cancer. Minn Med. 2005;88(4):45\u20139.","journal-title":"Minn Med"},{"issue":"5","key":"1544_CR27","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/pbc.21335","volume":"50","author":"MM Hawkins","year":"2008","unstructured":"Hawkins MM, Lancashire ER, Winter DL, Frobisher C, Reulen RC, Taylor AJ, et al. The British Childhood Cancer Survivor Study: objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer. 2008;50(5):1018\u201325.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1544_CR28","doi-asserted-by":"publisher","first-page":"e0151966","DOI":"10.1371\/journal.pone.0151966","volume":"11","author":"L Mader","year":"2016","unstructured":"Mader L, Rueegg CS, Vetsch J, Rischewski J, Ansari M, Kuehni CE, et al. Employment situation of parents of long-term childhood cancer survivors. PLoS ONE. 2016;11(3):e0151966.","journal-title":"PLoS ONE"},{"issue":"11","key":"1544_CR29","doi-asserted-by":"publisher","first-page":"e29958","DOI":"10.1002\/pbc.29958","volume":"69","author":"FN Belle","year":"2022","unstructured":"Belle FN, Slama T, Schindera C, Diesch-Furlanetto T, Kartal-Kaess M, Kuehni CE, et al. Body image in adolescent survivors of childhood cancer: the role of chronic health conditions. Pediatr Blood Cancer. 2022;69(11):e29958.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"1544_CR30","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/pbc.21145","volume":"48","author":"D Pollono","year":"2007","unstructured":"Pollono D, Rey G, Latella A, Rosso D, Chantada G, Braier J. Reactivation and risk of sequelae in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007;48(7):696\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1544_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13023-022-02436-0","volume":"17","author":"HC Cai","year":"2022","unstructured":"Cai HC, Chen J, Liu T, Cai H, Duan MH, Li J, et al. Langerhans cell histiocytosis in adolescent patients: a single-centre retrospective study. Orphanet J Rare Dis. 2022;17(1):268.","journal-title":"Orphanet J Rare Dis"},{"key":"1544_CR32","unstructured":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1\u2013253."},{"issue":"1","key":"1544_CR33","doi-asserted-by":"publisher","first-page":"e27438","DOI":"10.1002\/pbc.27438","volume":"66","author":"R Kasteler","year":"2019","unstructured":"Kasteler R, Belle F, Schindera C, Barben J, Gumy-Pause F, Tinner EM, et al. Prevalence and reasons for smoking in adolescent Swiss childhood cancer survivors. Pediatr Blood Cancer. 2019;66(1):e27438.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1544_CR34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/pbc.24821","volume":"61","author":"L Wengenroth","year":"2014","unstructured":"Wengenroth L, Rueegg CS, Michel G, Essig S, Ammann RA, Bergstraesser E, et al. Life partnerships in childhood cancer survivors, their siblings, and the general population. Pediatr Blood Cancer. 2014;61(3):538\u201345.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"1544_CR35","doi-asserted-by":"publisher","first-page":"e020282","DOI":"10.1136\/bmjopen-2017-020282","volume":"8","author":"W Hinton","year":"2018","unstructured":"Hinton W, McGovern A, Coyle R, Han TS, Sharma P, Correa A, et al. Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC). BMJ Open. 2018;8(8):e020282.","journal-title":"BMJ Open"},{"issue":"3","key":"1544_CR36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3803\/EnM.2013.28.3.180","volume":"28","author":"J Lee","year":"2013","unstructured":"Lee J, Lee S, Jang S, Ryu OH. Age-related changes in the prevalence of osteoporosis according to gender and skeletal site: the Korea National Health and Nutrition Examination Survey 2008\u20132010. Endocrinol Metab (Seoul). 2013;28(3):180\u201391.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"6","key":"1544_CR37","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1210\/jc.2008-2291","volume":"94","author":"SH Golden","year":"2009","unstructured":"Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009;94(6):1853\u201378.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1544_CR38","first-page":"385","volume":"78","author":"R Zachoval","year":"2013","unstructured":"Zachoval R, Krhut J, Sottner O, Hanus T, Martan A, Horcicka L, et al. Nocturnal polyuria, treatment with desmopressin. Ceska Gynekol. 2013;78(4):385\u20139.","journal-title":"Ceska Gynekol"},{"issue":"1","key":"1544_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/bjh.12598","volume":"164","author":"AL Alloin","year":"2014","unstructured":"Alloin AL, Barlogis V, Auquier P, Contet A, Poiree M, Demeocq F, et al. Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study. Br J Haematol. 2014;164(1):94\u2013100.","journal-title":"Br J Haematol"},{"issue":"2","key":"1544_CR40","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/pbc.21259","volume":"50","author":"S Imashuku","year":"2008","unstructured":"Imashuku S, Okazaki N, Nakayama M, Fujita N, Fukuyama T, Koike K, et al. Treatment of neurodegenerative CNS disease in Langerhans cell histiocytosis with a combination of intravenous immunoglobulin and chemotherapy. Pediatr Blood Cancer. 2008;50(2):308\u201311.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"1544_CR41","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00415-014-7375-y","volume":"261","author":"L Le Guennec","year":"2014","unstructured":"Le Guennec L, Decaix C, Donadieu J, Santiago-Ribeiro M, Martin-Duverneuil N, Levy R, et al. The cognitive spectrum in neurodegenerative Langerhans cell histiocytosis. J Neurol. 2014;261(8):1537\u201343.","journal-title":"J Neurol"},{"issue":"3","key":"1544_CR42","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/pbc.22326","volume":"54","author":"CE Allen","year":"2010","unstructured":"Allen CE, Flores R, Rauch R, Dauser R, Murray JC, Puccetti D, et al. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine\/cytosine arabinoside. Pediatr Blood Cancer. 2010;54(3):416\u201323.","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"1544_CR43","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1007\/s10072-022-06180-y","volume":"43","author":"L Autier","year":"2022","unstructured":"Autier L, Gaymard B, Bayen E, Del Cul A, Cohen-Aubart F, Martin-Duverneuil N, et al. Eye movement abnormalities in neurodegenerative langerhans cell histiocytosis. Neurol Sci. 2022;43(11):6539\u201346.","journal-title":"Neurol Sci"},{"issue":"4","key":"1544_CR44","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/bjh.15577","volume":"183","author":"S Heritier","year":"2018","unstructured":"Heritier S, Barkaoui MA, Miron J, Thomas C, Moshous D, Lambilliotte A, et al. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study. Br J Haematol. 2018;183(4):608\u201317.","journal-title":"Br J Haematol"},{"issue":"5","key":"1544_CR45","doi-asserted-by":"publisher","first-page":"e0176442","DOI":"10.1371\/journal.pone.0176442","volume":"12","author":"CS Rueegg","year":"2017","unstructured":"Rueegg CS, Gianinazzi ME, Michel G, Zwahlen M, von der Weid NX, Kuehni CE, et al. No evidence of response bias in a population-based childhood cancer survivor questionnaire survey - results from the Swiss Childhood Cancer Survivor Study. PLoS ONE. 2017;12(5):e0176442.","journal-title":"PLoS ONE"},{"issue":"8","key":"1544_CR46","first-page":"11","volume":"30","author":"PL Ramage-Morin","year":"2019","unstructured":"Ramage-Morin PL, Banks R, Pineault D, Atrach M. Unperceived hearing loss among Canadians aged 40 to 79. Health Rep. 2019;30(8):11\u201320.","journal-title":"Health Rep"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01544-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-024-01544-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01544-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:40:09Z","timestamp":1757101209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-024-01544-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1007\/s11764-024-01544-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3029147\/v1","asserted-by":"object"}]},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]},"assertion":[{"value":"26 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Canton of Bern (166\/2014; 2021\u201301462) granted ethical approval for ChCR and SCCSS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants or their parents provided their informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}